These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 10537059)
1. Transport of cationized anti-tetanus Fab'2 fragments across an in vitro blood-brain barrier model: involvement of the transcytosis pathway. Girod J; Fenart L; Régina A; Dehouck MP; Hong G; Scherrmann JM; Cecchelli R; Roux F J Neurochem; 1999 Nov; 73(5):2002-8. PubMed ID: 10537059 [TBL] [Abstract][Full Text] [Related]
2. [Cationization, a process for the delivery of antibodies to the central nervous system. Problems encountered in its application for immunotherapy strategies such as those for clostridial poisoning]. Hervé F; Ouzilou-Girod J; Scherrmann JM J Soc Biol; 2001; 195(3):201-27. PubMed ID: 11833458 [TBL] [Abstract][Full Text] [Related]
3. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor. Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898 [TBL] [Abstract][Full Text] [Related]
4. Enhanced cellular uptake and transport of polyclonal immunoglobulin G and fab after their cationization. Hong G; Chappey O; Niel E; Scherrmann JM J Drug Target; 2000; 8(2):67-77. PubMed ID: 10852339 [TBL] [Abstract][Full Text] [Related]
5. In vitro models for the blood-brain barrier. Garberg P; Ball M; Borg N; Cecchelli R; Fenart L; Hurst RD; Lindmark T; Mabondzo A; Nilsson JE; Raub TJ; Stanimirovic D; Terasaki T; Oberg JO; Osterberg T Toxicol In Vitro; 2005 Apr; 19(3):299-334. PubMed ID: 15713540 [TBL] [Abstract][Full Text] [Related]
6. Physiological pathway for low-density lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro. Candela P; Gosselet F; Miller F; Buee-Scherrer V; Torpier G; Cecchelli R; Fenart L Endothelium; 2008; 15(5-6):254-64. PubMed ID: 19065317 [TBL] [Abstract][Full Text] [Related]
7. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier. Lu W; Tan YZ; Hu KL; Jiang XG Int J Pharm; 2005 May; 295(1-2):247-60. PubMed ID: 15848009 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier. Fenart L; Casanova A; Dehouck B; Duhem C; Slupek S; Cecchelli R; Betbeder D J Pharmacol Exp Ther; 1999 Dec; 291(3):1017-22. PubMed ID: 10565819 [TBL] [Abstract][Full Text] [Related]
9. Brain iron homeostasis. Moos T Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165 [TBL] [Abstract][Full Text] [Related]
10. Establishment of coculture model of blood-brain barrier in vitro for nanoparticle's transcytosis and toxicity evaluation. Lu W; Tan YZ; Jiang XG Yao Xue Xue Bao; 2006 Apr; 41(4):296-304. PubMed ID: 16856472 [TBL] [Abstract][Full Text] [Related]
11. A dynamic model of the blood-brain barrier "in vitro". Stanness KA; Guatteo E; Janigro D Neurotoxicology; 1996; 17(2):481-96. PubMed ID: 8856743 [TBL] [Abstract][Full Text] [Related]
12. Protein transport in cerebral endothelium. In vitro transcytosis of transferrin. Fenart L; Cecchelli R Methods Mol Med; 2003; 89():277-90. PubMed ID: 12958427 [No Abstract] [Full Text] [Related]
13. Anti idiotypic recognition of auto and allo antibodies to factor VIII by immunoglobulin preparations from single blood donors and large plasma pool. Sultan Y; Rossi F; Kazatchkine M Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):539-43. PubMed ID: 1714857 [TBL] [Abstract][Full Text] [Related]
14. Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. van Bree JB; de Boer AG; Danhof M; Ginsel LA; Breimer DD J Pharmacol Exp Ther; 1988 Dec; 247(3):1233-9. PubMed ID: 3204515 [TBL] [Abstract][Full Text] [Related]
15. Transport of vasopressin fragments across the blood-brain barrier: in vitro studies using monolayer cultures of bovine brain endothelial cells. van Bree JB; de Boer AG; Verhoef JC; Danhof M; Breimer DD J Pharmacol Exp Ther; 1989 Jun; 249(3):901-5. PubMed ID: 2732952 [TBL] [Abstract][Full Text] [Related]
16. The MAP kinase pathway mediates transcytosis induced by TNF-alpha in an in vitro blood-brain barrier model. Miller F; Fenart L; Landry V; Coisne C; Cecchelli R; Dehouck MP; Buée-Scherrer V Eur J Neurosci; 2005 Aug; 22(4):835-44. PubMed ID: 16115207 [TBL] [Abstract][Full Text] [Related]
17. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier. Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564 [TBL] [Abstract][Full Text] [Related]
18. Solution structure of human and mouse immunoglobulin M by synchrotron X-ray scattering and molecular graphics modelling. A possible mechanism for complement activation. Perkins SJ; Nealis AS; Sutton BJ; Feinstein A J Mol Biol; 1991 Oct; 221(4):1345-66. PubMed ID: 1942055 [TBL] [Abstract][Full Text] [Related]
20. Developmental aspects of blood-brain barrier (BBB) and rat brain endothelial (RBE4) cells as in vitro model for studies on chlorpyrifos transport. Yang J; Aschner M Neurotoxicology; 2003 Aug; 24(4-5):741-5. PubMed ID: 12900088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]